BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Chakravarthy MV, Waddell T, Banerjee R, Guess N. Nutrition and Nonalcoholic Fatty Liver Disease. Gastroenterology Clinics of North America 2020;49:63-94. [DOI: 10.1016/j.gtc.2019.09.003] [Cited by in Crossref: 28] [Cited by in F6Publishing: 20] [Article Influence: 14.0] [Reference Citation Analysis]
Number Citing Articles
1 Romero-gómez M, Aller R, Martín-bermudo F. Dietary Recommendations for the Management of Non-alcoholic Fatty Liver Disease (NAFLD): A Nutritional Geometry Perspective. Semin Liver Dis 2022. [DOI: 10.1055/s-0042-1757711] [Reference Citation Analysis]
2 Mastromauro C, Polidori N, Giannini C. Metabolic dysfunction-associated fatty liver disease in obese youth with insulin resistance and type 2 diabetes. Curr Opin Pediatr 2022;34:414-22. [PMID: 35836399 DOI: 10.1097/MOP.0000000000001138] [Reference Citation Analysis]
3 Bauer KC, Littlejohn PT, Ayala V, Creus-Cuadros A, Finlay BB. Nonalcoholic Fatty Liver Disease and the Gut-Liver Axis: Exploring an Undernutrition Perspective. Gastroenterology 2022;162:1858-1875.e2. [PMID: 35248539 DOI: 10.1053/j.gastro.2022.01.058] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 7.0] [Reference Citation Analysis]
4 Darabi Z, Webb RJ, Mozaffari-khosravi H, Mirzaei M, Davies IG, Khayyatzadeh SS, Mazidi M. Dietary phytochemical consumption is inversely associated with liver alkaline phosphatase in Middle Eastern adults. WJH 2022;14:1007-16. [DOI: 10.4254/wjh.v14.i5.1007] [Reference Citation Analysis]
5 Darabi Z, Webb RJ, Mozaffari-Khosravi H, Mirzaei M, Davies IG, Khayyatzadeh SS, Mazidi M. Dietary phytochemical consumption is inversely associated with liver alkaline phosphatase in Middle Eastern adults. World J Hepatol 2022; 14(5): 1006-1015 [DOI: 10.4254/wjh.v14.i5.1006] [Reference Citation Analysis]
6 Waddell T, Bagur A, Cunha D, Thomaides-Brears H, Banerjee R, Cuthbertson DJ, Brown E, Cusi K, Després JP, Brady M. Greater ectopic fat deposition and liver fibroinflammation, and lower skeletal muscle mass in people with type 2 diabetes. Obesity (Silver Spring) 2022. [PMID: 35475573 DOI: 10.1002/oby.23425] [Reference Citation Analysis]
7 Kilinç A, Akdevelioğlu Y. Vitaminler ve Non Alkolik Yağlı Karaciğer Hastalığı. Adnan Menderes Üniversitesi Sağlık Bilimleri Fakültesi Dergisi 2022. [DOI: 10.46237/amusbfd.1033604] [Reference Citation Analysis]
8 Gindlhuber J, Schinagl M, Liesinger L, Darnhofer B, Tomin T, Schittmayer M, Birner-gruenberger R. Hepatocyte Proteome Alterations Induced by Individual and Combinations of Common Free Fatty Acids. IJMS 2022;23:3356. [DOI: 10.3390/ijms23063356] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
9 Drummer CIV, Saaoud F, Sun Y, Atar D, Xu K, Lu Y, Shao Y, Johnson C, Liu L, Shen H, Jhala NC, Jiang X, Wang H, Yang X. Hyperlipidemia May Synergize with Hypomethylation in Establishing Trained Immunity and Promoting Inflammation in NASH and NAFLD. J Immunol Res 2021;2021:3928323. [PMID: 34859106 DOI: 10.1155/2021/3928323] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
10 Kotlyarov S, Bulgakov A. Lipid Metabolism Disorders in the Comorbid Course of Nonalcoholic Fatty Liver Disease and Chronic Obstructive Pulmonary Disease. Cells 2021;10:2978. [PMID: 34831201 DOI: 10.3390/cells10112978] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
11 He Z, Li X, Yang H, Wu P, Wang S, Cao D, Guo X, Xu Z, Gao J, Zhang W, Luo X. Effects of Oral Vitamin C Supplementation on Liver Health and Associated Parameters in Patients With Non-Alcoholic Fatty Liver Disease: A Randomized Clinical Trial. Front Nutr 2021;8:745609. [PMID: 34595203 DOI: 10.3389/fnut.2021.745609] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 7.0] [Reference Citation Analysis]
12 Ristic-Medic D, Petrovic S, Arsic A, Vucic V. Liver disease and COVID-19: The link with oxidative stress, antioxidants and nutrition. World J Gastroenterol 2021; 27(34): 5682-5699 [PMID: 34629794 DOI: 10.3748/wjg.v27.i34.5682] [Cited by in CrossRef: 7] [Cited by in F6Publishing: 7] [Article Influence: 7.0] [Reference Citation Analysis]
13 Bonsembiante L, Targher G, Maffeis C. Non-alcoholic fatty liver disease in obese children and adolescents: a role for nutrition? Eur J Clin Nutr 2021. [PMID: 34006994 DOI: 10.1038/s41430-021-00928-z] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 9.0] [Reference Citation Analysis]
14 Jiang G, Ramachandraiah K, Murtaza MA, Wang L, Li S, Ameer K. Synergistic effects of black ginseng and aged garlic extracts for the amelioration of nonalcoholic fatty liver disease (NAFLD) in mice. Food Sci Nutr 2021;9:3091-9. [PMID: 34136174 DOI: 10.1002/fsn3.2267] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
15 Vancells Lujan P, Viñas Esmel E, Sacanella Meseguer E. Overview of Non-Alcoholic Fatty Liver Disease (NAFLD) and the Role of Sugary Food Consumption and Other Dietary Components in Its Development. Nutrients 2021;13:1442. [PMID: 33923255 DOI: 10.3390/nu13051442] [Cited by in Crossref: 27] [Cited by in F6Publishing: 28] [Article Influence: 27.0] [Reference Citation Analysis]
16 Roca-Fernández A, Dennis A, Nicholls R, McGonigle J, Kelly M, Banerjee R, Banerjee A, Sanyal AJ. Hepatic Steatosis, Rather Than Underlying Obesity, Increases the Risk of Infection and Hospitalization for COVID-19. Front Med (Lausanne) 2021;8:636637. [PMID: 33855033 DOI: 10.3389/fmed.2021.636637] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 7.0] [Reference Citation Analysis]
17 Abd El-wahab A, Chuppava B, Radko D, Visscher C. Hepatic lipidosis in fattening turkeys: A review. Ger J Vet Res 2021;1:48-66. [DOI: 10.51585/gjvr.2021.3.0022] [Reference Citation Analysis]
18 Rahman MM, Kibria MG, Begum H, Haque M, Sultana N, Akhter M, Rowshon AHM, Ahmed F, Hasan M. Prevalence, risk factors and metabolic profile of the non-obese and obese non-alcoholic fatty liver disease in a rural community of South Asia. BMJ Open Gastroenterol 2020;7:e000535. [PMID: 33376110 DOI: 10.1136/bmjgast-2020-000535] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
19 Rives C, Fougerat A, Ellero-Simatos S, Loiseau N, Guillou H, Gamet-Payrastre L, Wahli W. Oxidative Stress in NAFLD: Role of Nutrients and Food Contaminants. Biomolecules 2020;10:E1702. [PMID: 33371482 DOI: 10.3390/biom10121702] [Cited by in Crossref: 34] [Cited by in F6Publishing: 35] [Article Influence: 17.0] [Reference Citation Analysis]
20 Lin CW, Huang TW, Peng YJ, Lin YY, Mersmann HJ, Ding ST. A novel chicken model of fatty liver disease induced by high cholesterol and low choline diets. Poult Sci 2021;100:100869. [PMID: 33516481 DOI: 10.1016/j.psj.2020.11.046] [Cited by in Crossref: 8] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
21 Shen S, Wang K, Zhi Y, Shen W, Huang L. Gypenosides improves nonalcoholic fatty liver disease induced by high-fat diet induced through regulating LPS/TLR4 signaling pathway. Cell Cycle 2020;19:3042-53. [PMID: 33121337 DOI: 10.1080/15384101.2020.1829800] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
22 Tricò D, Biancalana E, Solini A. Protein and amino acids in nonalcoholic fatty liver disease. Curr Opin Clin Nutr Metab Care 2021;24:96-101. [PMID: 33060460 DOI: 10.1097/MCO.0000000000000706] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 7.5] [Reference Citation Analysis]
23 Hamill MJ, Afeyan R, Chakravarthy MV, Tramontin T. Endogenous Metabolic Modulators: Emerging Therapeutic Potential of Amino Acids. iScience 2020;23:101628. [PMID: 33103071 DOI: 10.1016/j.isci.2020.101628] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
24 Tamitani M, Yamamoto T, Yamamoto N, Fujisawa K, Tanaka S, Nakamura Y, Uchinoumi H, Oda T, Okuda S, Takami T, Kobayashi S, Sakaida I, Yano M. Dantrolene prevents hepatic steatosis by reducing cytoplasmic Ca2+ level and ER stress. Biochemistry and Biophysics Reports 2020;23:100787. [DOI: 10.1016/j.bbrep.2020.100787] [Reference Citation Analysis]
25 Cheng X, Liu N, Liu H, Huang N, Sun X, Zhang G. Bioinformatic and biochemical findings disclosed anti-hepatic steatosis mechanism of calycosin. Bioorg Chem 2020;100:103914. [PMID: 32417523 DOI: 10.1016/j.bioorg.2020.103914] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
26 [DOI: 10.1101/2020.06.04.20122457] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Reference Citation Analysis]